On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
Vilsbøll
Tina
T
Department of Internal Medicine F and Clinical Pharmacology, Gentofte Hospital, The Panum Institute, Kratmosevej 11, DK-2950 Vedbaek, Denmark.
D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D005749:Gastric Inhibitory Polypeptide / Q000502:physiology*; D052216:Glucagon-Like Peptide 1 / Q000502:physiology*; D053767:Glucagon-Like Peptide 2; D004763:Glucagon-Like Peptides / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion
D053767:Glucagon-Like Peptide 2; D007328:Insulin; D005749:Gastric Inhibitory Polypeptide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1